Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity
The Effect of Cycling Priming Coordination Training on Ataxia and Brain Plasticity
1 other identifier
interventional
40
1 country
1
Brief Summary
Effective walking and balance require not only lower limb muscle strength but also coordinated movement. For individuals with Spinocerebellar Ataxia (SCA), rehabilitation strategies targeting coordination are essential to improving mobility and reducing the burden on caregivers. However, evidence-based rehabilitation approaches for ataxia remain limited. Recent studies suggest that improvements in motor learning are often accompanied by changes in cortical excitability. Abnormal cortical excitability in SCA patients may hinder rehabilitation efforts, yet priming strategies-such as exercise or specific stimuli-have been shown to enhance motor learning by modulating cortical excitability. Cycling exercise, in particular, has demonstrated the potential to improve coordination and influence cortical plasticity in individuals with SCA, making it a promising priming strategy for coordination training. This clinical trial aims to:
- 1.Investigate the priming effect and neural mechanisms of acute cycling exercise on coordination training in patients with SCA.
- 2.Explore the long-term impact of priming cycling training on cortical plasticity and functional mobility in individuals with SCA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
October 8, 2024
October 1, 2024
1.8 years
September 13, 2024
October 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Overall Response Time
The sum of reaction time and movement time, providing a complete measure of the time taken from the stimulus presentation to the completion of the response. Unit: Second(s)
Baseline, 2 weeks and 4 weeks
Overall Error Rate
The total proportion of incorrect responses across a testing session or series of tasks.
Baseline, 2 weeks and 4 weeks
Motor Evoked Potentials (MEPs)
MEPs are the electrical responses recorded from muscles following stimulation of the motor cortex. They reflect the efficiency of neural transmission from the cortex to the muscle. Unit: millivolts (mV).
Baseline, 2 weeks and 4 weeks
Intracortical Facilitation (ICF)
ICF is measured by applying a pair of TMS pulses with a short interval (e.g., 8-15 ms) where the first (subthreshold) pulse is followed by a second (suprathreshold) pulse, leading to an increased amplitude of the MEP.
Baseline, 2 weeks and 4 weeks
Intracortical Inhibition (ICI)
ICI is measured similarly to ICF but with a shorter inter-stimulus interval (e.g., 1-5 ms), resulting in a suppressed MEP amplitude. This suppression reflects inhibitory processes within the cortex.
Baseline, 2 weeks, and 4 weeks
Total Scale for the Assessment and Rating of Ataxia (SARA) Score
To objectively assess ataxia severity across various domains of motor function including gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movements, and heel-shin slide. Each item is scored individually with a scale that typically ranges from 0 (no ataxia) to a maximum score that depends on the severity and the aspect of ataxia being assessed. The total score ranges from 0 (no ataxia) to 40 (most severe ataxia).
Baseline, 2 weeks, and 4 weeks
Total Berg Balance Scale (BBS) Score
To measure an individual's balance abilities through various tasks that mimic daily activities, assessing the risk of falls and overall balance proficiency. The BBS consists of 14 items that evaluate a range of functions including sitting to standing, standing unsupported, transferring, turning to look behind, picking up an object from the floor, and standing on one leg. Each task is rated on a scale from 0 (unable) to 4 (independent), with the total score ranging from 0 to 56. A higher total score indicates better balance and lower fall risk. Scores below 45 are generally indicative of increased fall risk.
Baseline, 2 weeks, and 4 weeks
Total Time to Complete the Time Up and Go test (TUG test)
The time, in seconds, it takes for a participant to complete the TUG test from the initial sitting position to returning to the seated position. An older adult who takes ≥12 seconds to complete the TUG is at risk for falling.
Baseline, 2 weeks, and 4 weeks
Walking Speed
The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s).
Baseline, 2 weeks, and 4 weeks
Step Length
The linear distance between the two ankles, typically expressed in centimeter(cm).
Baseline, 2 weeks, and 4 weeks
Step Time
The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds.
Baseline, 2 weeks, and 4 weeks
Fatigue Level Measurement Using Multidimensional Fatigue Inventory (MFI)
The MFI is a 20-item self-report questionnaire used to measure five dimensions of fatigue: general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation. Each dimension is scored separately, with higher scores indicating greater fatigue
Baseline, 2 weeks, and 4 weeks
Sleep Quality Measurement Using Pittsburgh Sleep Quality Index (PSQI)
The PSQI is a 19-item self-report questionnaire that assesses sleep quality over a 1-month period. It generates a global score ranging from 0 to 21, with higher scores indicating poorer sleep quality. The PSQI includes seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction.
Baseline, 2 weeks, and 4 weeks
Secondary Outcomes (6)
Gait Speed Measurement Using 10-Meter Walk Test (10MWT)
Baseline, 2 weeks, and 4 weeks
Double Support Time
Baseline, 2 weeks, and 4 weeks
Single Support Time
Baseline, 2 weeks, and 4 weeks
Swing Time
Baseline, 2 weeks, and 4 weeks
Stance Time
Baseline, 2 weeks, and 4 weeks
- +1 more secondary outcomes
Study Arms (2)
SCA training group
EXPERIMENTALLong-term training
SCA Control group
NO INTERVENTIONControl group
Interventions
Cycling combined with priming strategies to enhance motor learning tasks. Each session will last for 15 minutes, conducted three times per week, over a period of two weeks.
Eligibility Criteria
You may qualify if:
- \- Clinical diagnosis of SCA.
You may not qualify if:
- Musculoskeletal injuries on legs
- Osteoporosis.
- Any peripheral or central nervous system injury or disease patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung University
Taoyuan District, 333, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 13, 2024
First Posted
September 19, 2024
Study Start
October 4, 2024
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
October 8, 2024
Record last verified: 2024-10